Healthcare · Drug Manufacturers General · NYSE
| Market cap | $434.78B |
|---|---|
| Trailing P/E | 22.6 |
| FCF yield | 4.1% |
| Revenue growth (YoY) | +8.6% |
| EPS growth (YoY) | -1.2% |
| FCF/share growth (YoY) | -0.1% |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Drug Manufacturers General |
AbbVie Inc. trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →
| Member | Chamber | Trade | Amount | Disclosed |
|---|---|---|---|---|
| Josh Gottheimer | House | Sell | $1,001 - $15,000 | Jun 2, 2026 |
| Julia Letlow | House | Sell | $1,001 - $15,000 | Jan 1, 2026 |
| Lisa McClain | House | Buy | $1,001 - $15,000 | Nov 1, 2025 |
| Julia Letlow | House | Sell | $1,001 - $15,000 | Aug 11, 2025 |
| Ritchie John Torres | House | Sell | $1,001 - $15,000 | Aug 1, 2025 |
| Josh Gottheimer | House | Sell | $1,001 - $15,000 | May 13, 2025 |
| Josh Gottheimer | House | Buy | $1,001 - $15,000 | May 12, 2025 |
| Rob Bresnahan | House | Buy | $1,001 - $15,000 | Feb 25, 2025 |
| Jared Moskowitz | House | Buy | $1,001 - $15,000 | Jan 31, 2025 |
| John James | House | Sell | $1,001 - $15,000 | Sep 5, 2024 |
| John James | House | Buy | $1,001 - $15,000 | Aug 13, 2024 |
| Greg Stanton | House | Sell | $1,001 - $15,000 | Oct 26, 2023 |